Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MSL3 |
| Upstream (Parents) |
|---|
| (<<) PAX7 → MSL3 |
| (<<) IRF1 → MSL3 |
| (<<) SCML1 → MSL3 |
| (<<) L3MBTL4 → MSL3 |
| (<<) TULP4 → MSL3 |
| (<<) HES1 → MSL3 |
| (<<) C5orf41 → MSL3 |
| (<<) POU4F1 → MSL3 |
| (<<) CREB1 → MSL3 |
| (<<) TFCP2 → MSL3 |
| (<<) C2orf3 → MSL3 |
| (<<) ZNF281 → MSL3 |
| (<<) RXRB → MSL3 |
| (<<) HMG20B → MSL3 |
| (<<) PTTG1 → MSL3 |
| (<<) ELF4 → MSL3 |
| (<<) FOXO1 → MSL3 |
| (<<) ELF1 → MSL3 |
| (<<) STAT2 → MSL3 |
| Downstream (Children) |
|---|
| MSL3 → SIX2 (>>) |
| MSL3 → CREB5 (>>) |
| MSL3 → PBX1 (>>) |
| MSL3 → ETS1 (>>) |
| MSL3 → SMAD1 (>>) |
| MSL3 → PAX3 (>>) |
| MSL3 → ZKSCAN1 (>>) |
| MSL3 → HDX (>>) |
| MSL3 → HOXD4 (>>) |
| MSL3 → FOXL2 (>>) |
| MSL3 → NFE2L2 (>>) |
| MSL3 → SCML2 (>>) |
